Clinical Trial

IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients

Study acronym: IoN
Active, Not Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
IoN is a phase II/III trial that will look to ascertain whether or not radio-iodine ablation is necessary for low risk differentiated thyroid cancer patients.
Protocol Amendment History 16 amendments
This ClinicalTrials.gov record has been amended 16 times since 2011-07-18; most recent amendment 2026-05-01.
Status change: Recruiting → Active, Not Recruiting 2020-11-04
Status change: Not Yet Recruiting → Recruiting 2012-05-29
Trial Details
NCT Number NCT01398085
Lead Sponsor University College, London
Collaborators: Cancer Research UK
Conditions Thyroid Cancer, Thyroid Neoplasms
Enrollment 504 participants
Start Date 2012-06-26
Primary Completion 2031-03 (estimated)
Study Completion 2031-03 (estimated)
Updated on ClinicalTrials.gov 2026-05-07